Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice. (Q54047539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

M J Ehrke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D L Maccubbin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Ujházy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G Zaleskis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Berleth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Mihich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

101-109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

Thymic hyperplasia following successful chemotherapy. A report of two cases and review of the literature

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-alpha therapy: phenotypic and functional characterization up to 20 months after initial tumor inoculation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Novel muteins of human tumor necrosis factor with potent antitumor activity and less lethal toxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Clinicopathological diagnosis and treatment of malignant histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Clinical effect of intra-arterial tumor necrosis factor-alpha for malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Thymic atrophy and regrowth in response to chemotherapy: CT evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Programmed cell death in the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Cyclophosphamide plus tumor necrosis factor-alpha chemoimmunotherapy cured mice: life-long immunity and rejection of re-implanted primary lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Clinical applications of TNF-alpha in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

Thymic hyperplasia in adults following chemotherapy for malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000701%2987%3A1%3C101%3A%3AAID-IJC15%3E3.0.CO%3B2-B

10.1002/1097-0215(20000701)87:1<101::AID-IJC15>3.0.CO;2-B

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10861459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference